RESECTABLE PANCREATIC CARCINOMA
Clinical trials for RESECTABLE PANCREATIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE PANCREATIC CARCINOMA trials appear
Sign up with your email to follow new studies for RESECTABLE PANCREATIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for pancreatic cancer: targeted drug may delay return in BRCA patients
Disease control Recruiting nowThis phase II trial is testing whether the drug olaparib can help prevent pancreatic cancer from coming back in people who have already had surgery and chemotherapy and carry a BRCA1, BRCA2, or PALB2 mutation. Olaparib is a targeted therapy that blocks a repair enzyme cancer cell…
Matched conditions: RESECTABLE PANCREATIC CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New microscope peers inside living tumors to see how they behave
Knowledge-focused Recruiting nowThis study uses a special microscope called intravital microscopy to look at blood vessels inside solid tumors while patients are in surgery. Researchers want to see how these vessels work and how well they let blood and dye flow through. The goal is to learn whether tumor vessel…
Matched conditions: RESECTABLE PANCREATIC CARCINOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC